clinical trials
Evaluating Epigenome-Targeting Cancer Therapies
Evaluating Epigenome-Targeting Cancer Therapies
Jef Akst | Apr 3, 2017
At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.
Rethinking a Cancer Drug Target
Rethinking a Cancer Drug Target
Catherine Offord | Mar 26, 2017
The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.
Women Lose Vision After Stem Cell Treatment
Women Lose Vision After Stem Cell Treatment
Kerry Grens | Mar 17, 2017
The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration. 
Kite’s CAR T-Cell Therapy Success
Kite’s CAR T-Cell Therapy Success
Jef Akst | Mar 1, 2017
More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.
HIV Vaccines May Help Tamp Down Virus
HIV Vaccines May Help Tamp Down Virus
Kerry Grens | Feb 24, 2017
A fraction of HIV patients in a small, uncontrolled study were able to stop antiretroviral therapy after receiving the immune boosters.
Regulators OK Clinical Trials Using Donor Stem Cells
Regulators OK Clinical Trials Using Donor Stem Cells
Kerry Grens | Feb 6, 2017
Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Infographic: The Cost of Drug Development
Infographic: The Cost of Drug Development
John D. Loike and Jennifer Miller | Feb 1, 2017
Expensive clinical trials and few drug approvals can drive up drug prices for consumers.
Pharma Cooperates to Achieve Precision Medicine
Pharma Cooperates to Achieve Precision Medicine
Catherine Offord | Feb 1, 2017
The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.
Marijuana Research Still Stymied by Federal Laws
Marijuana Research Still Stymied by Federal Laws
Bob Grant | Jan 23, 2017
US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.